Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical tranexamic acid for bone fracture healing
IRCT20250226064858N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tranexamic acid in tibia fracture and femoral fracture (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Time of bone fusion, Lane and Sandhu radiographic union score at week 4 and 6 more. Started Mar 2025; status: completed.
02
Drugs
tranexamic acid
03
Conditions
tibia fracturefemoral fracture
Beyond the preview
Go deeper on IRCT20250226064858N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250226064858N1.